EraGen Partners with Illumina to Develop Molecular Dx Assays
November 18, 2009
EraGen Partners with Illumina to Develop Molecular Dx Assays
The companies will develop molecular-based, high-throughput, clinical assays using Eragen's MultiCode-PLx technology and Illumina's BeadXpress platform.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CGC Genetics Rolls out BeadXpress-based Test for Skeletal Dysplasia
July 17, 2012 / BioArray News - Luminex Looks to Target Mid- to Low-Volume MDx Labs with GenturaDx Platform
July 12, 2012 / PCR Insider - AmberGen Secures $600K to Develop Allergy Test on Illumina's BeadXpress Platform
May 15, 2012 / BioArray News - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
September 8, 2011 / PCR Insider - iGenix Debuts Illumina BeadXpress-based Warfarin PGx Test, Plans More Assays
July 26, 2011 / BioArray News